Nutritional and Botanical Approaches for Cognitive Health—Part 2

Mucke HA . The case of galantamine: Repurposing and late blooming of a cholinergic drug. Futur Sci OA, 2015; 1:FSO73.

Rainey-Smith SR , Brown BM , Sohrabi HR , et al. Curcumin and cognition: A randomised, placebo-controlled, double-blind study of community-dwelling older adults. Br J Nutr, 2016; 115:2106–2113.

Cox KH , Pipingas A , Scholey AB . Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol, 2015; 29:642–651.

Ringman JM , Frautschy SA , Teng E , et al. Oral curcumin for Alzheimer's disease: Tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther, 2012; 4:43.

Baum L , Lam CWK , Cheung SK-K , et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol, 2008; 28:110–113.

Siddiqui MZ . Boswellia serrata, a potential antiinflammatory agent: An overview. Indian J Pharm Sci, 2011; 73:255–261.

Bakthira H , Awadh Ali NA , Arnold N , et al. Anticholinesterase activity of endemic plant extracts from Soqotra. Afr J Tradit Complement Altern Med AJTCAM, 2011; 8:296–299.

Fathi E , Katouli FH , Riazi GH , et al. The effects of alpha boswellic acid on reelin expression and tau phosphorylation in human astrocytes. Neuromolecular Med, 2017; 19:136–146.

Taghizadeh M , Maghaminejad F , Aghajani M , et al. The effect of tablet containing Boswellia serrata and Melisa officinalis extract on older adults' memory: A randomized controlled trial. Arch Gerontol Geriatr, 2018; 75:146–150.

Sedighi B , Pardakhty A , Kamali H , et al. Effect of Boswellia papyrifera on cognitive impairment in multiple sclerosis. Iran J Neurol, 2014; 13:149–153.

Gauthier S , Schlaefke S . Efficacy and tolerability of Ginkgo biloba extract EGb 761^® in dementia: A systematic review and meta-analysis of randomized placebo-controlled trials. Clin Interv Aging, 2014; 9:2065–2077.

Tan M-S , Yu J-T , Tan C-C , et al. Efficacy and adverse effects of Ginkgo biloba for cognitive impairment and dementia: A systematic review and meta-analysis. J Alzheimer's Dis, 2014; 43:589–603.

Yang G , Wang Y , Sun J , et al. Ginkgo biloba for mild cognitive impairment and Alzheimer's disease: A Systematic review and meta-analysis of randomized controlled trials. Curr Top Med Chem, 2016; 16:520–528.

Naderi GA , Asgary S , Jafarian A , et al. Fibrinolytic effects of Ginkgo biloba extract. Exp Clin Cardiol, 2005; 10:85–87.

Shiyong Y , Yijia X , Peng Z , et al. Ginkgo biloba extract inhibits platelet activation via inhibition of Akt. Integr Med Int, 2015; 1:234–242.

Bal Dit Sollier C , Caplain H , Drouet L . No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clin Lab Haematol, 2003; 25:251–253.

Kellermann AJ , Kloft C . Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy, 2011; 31:490–502.

Gardner CD , Zehnder JL , Rigby AJ , et al. Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: A randomized clinical trial. Blood Coagul Fibrinolysis, 2007; 18:787–793.

Choi S , Oh D-S , Jerng UM . A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin. PLoS One, 2017; 12:e0182794.

Zhou X , Ma Z , Geng T , et al. Evaluation of in vitro inhibition and induction of cytochrome P450 activities by hydrolyzed ginkgolides. J Ethnopharmacol, 2014; 158:132–139.

Yale SH , Glurich I . Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. J Altern Complement Med, 2005; 11:433–439.

Zadoyan G , Rokitta D , Klement S , et al. Effect of Ginkgo biloba special extract EGb 761^® on human cytochrome P450 activity: A cocktail interaction study in healthy volunteers. Eur J Clin Pharmacol, 2012; 68:553–560.

Greenblatt DJ , von Moltke LL , Luo Y , et al. Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P450-2C9 substrate. J Clin Pharmacol, 2006; 46:214–221.

Gurley BJ , Gardner SF , Hubbard MA , et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba . Drugs Aging, 2005; 22:525–539.

Weiskirchen S , Weiskirchen R . Resveratrol: How much wine do you have to drink to stay healthy?. Adv Nutr, 2016; 7:706–718.

Ghanim H , Sia CL , Korzeniewski K , et al. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab, 2011; 96:1409–1414.

Wong RHX , Berry NM , Coates AM , et al. Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults. J Hypertens, 2013; 31:1819–1827.

Brown VA , Patel KR , Viskaduraki M , et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: Safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res, 2010; 70:9003–9011.

Gomes BAQ , Silva JPB , Romeiro CFR , et al. Neuroprotective mechanisms of resveratrol in Alzheimer's disease: Role of SIRT1. Oxid Med Cell Longev, 2018; 2018:1–15.

Bonfili L , Cecarini V , Cuccioloni M , et al. SLAB51 probiotic formulation activates SIRT1 pathway promoting antioxidant and neuroprotective effects in an AD mouse model. Mol Neurobiol, 2018; 55:7987–8000.

Lalla R , Donmez G . The role of sirtuins in Alzheimer's disease. Front Aging Neurosci, 2013; 5:16.

Turner RS , Thomas RG , Craft S , et al. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology, 2015; 85:1383–1391.

Bedada SK , Neerati P . Resveratrol pretreatment affects CYP2E1 activity of chlorzoxazone in healthy human volunteers. Phyther Res, 2016; 30:463–468.

Chow H-HS , Garland LL , Hsu C-H , et al. Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res, 2010; 3:1168–1175.

Brandalise F , Cesaroni V , Gregori A , et al. Dietary supplementation of Hericium erinaceus increases mossy fiber-CA3 hippocampal neurotransmission and recognition memory in wild-type mice. Evid Based Complement Alternat Med, 2017; 2017:3864340.

Tsai-Teng T , Chin-Chu C , Li-Ya L , et al. Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease-related pathologies in APPswe/PS1dE9 transgenic mice. J Biomed Sci, 2016; 23:49.

Mori K , Obara Y , Moriya T , et al. Effects of Hericium erinaceus on amyloid β(25–35) peptide-induced learning and memory deficits in mice. Biomed Res, 2011; 32:67–72.

Lai P-L , Naidu M , Sabaratnam V , et al. Neurotrophic properties of the Lion's mane medicinal mushroom, Hericium erinaceus (higher Basidiomycetes) from Malaysia. Int J Med Mushrooms, 2013; 15:539–554.

Eyjolfsdottir H . Nerve growth factor in Alzheimer's disease: Biological effects and therapeutic potential. 2017. Online document at: https://openarchive.ki.se/xmlui/handle/10616/45488 Accessed March 11, 2019 .

Eriksdotter Jönhagen M , Nordberg A , Amberla K , et al. Intracerebroventricular Infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord, 1998; 9:246–257.

Mori K , Inatomi S , Ouchi K , et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: A double-blind placebo-controlled clinical trial. Phyther Res, 2009; 23:367–372.

Wang K , Wang Z , Cui R , et al. Polysaccharopeptide from Trametes versicolor blocks inflammatory osteoarthritis pain-morphine tolerance effects via activating cannabinoid type 2 receptor. Int J Biol Macromol, 2019; 126:805–810.

Lim BO . Coriolus versicolor suppresses inflammatory bowel disease by inhibiting the expression of STAT1 and STAT6 associated with IFN-γ and IL-4 expression. Phyther Res, 2011; 25:1257–1261.

Fang X , Jiang Y , Ji H , et al. The synergistic beneficial effects of ginkgo flavonoid and Coriolus versicolor polysaccharide for memory improvements in a mouse model of dementia. Evid Based Complement Alternat Med, 2015; 2015:128394.

Wachtel-Galor S , Yuen J , Buswell JA , et al. Ganoderma lucidum (lingzhi or reishi): A medicinal mushroom. In Benzie IFF , Wachtel-Galor S , eds. Herbal Medicine: Biomolecular and Clinical Aspects, 2nd ed. Boca Raton, FL: CRC Press/Taylor & Francis, 2011.

Huang S , Mao J , Ding K , et al. Polysaccharides from Ganoderma lucidum promote cognitive function and neural progenitor proliferation in mouse model of Alzheimer's disease. Stem Cell Reports, 2017; 8:84–94.

Wang G , Wang L , Wang C , et al. Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease. Medicine (Baltimore), 2018; 97:e0636.

Qin L-H , Wang C , Qin L-W , et al. Spore powder of Ganoderma lucidum for Alzheimer's disease: A protocol for systematic review. Medicine (Baltimore), 2019; 98:e14382.

Calabrese C , Gregory WL , Leo M , et al. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: A randomized, double-blind, placebo-controlled trial. J Altern Complement Med, 2008; 14:707–713.

Morgan A , Stevens J . Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. J Altern Complement Med, 2010; 16:753–759.

Wattanathorn J , Mator L , Muchimapura S , et al. Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centella asiatica . J Ethnopharmacol, 2008; 116:325–332.

Farhana KM , Malueka RG , Wibowo S , et al. Effectiveness of Gotu kola extract 750 mg and 1000 mg compared with folic acid 3 mg in improving vascular cognitive impairment after stroke. Evid Based Complement Alternat Med, 2016; 2016:2795915.

Yang G , Wang Y , Tian J , et al. Huperzine A for Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials. PLoS One, 2013; 8:e74916.

Li J , Wu HM , Zhou RL , et al. Huperzine A for Alzheimer's disease. Cochrane Database Syst Rev, 2008; 2:CD005592.

Moss M , Smith E , Milner M , et al. Acute ingestion of rosemary water: Evidence of cognitive and cerebrovascular effects in healthy adults. J Psychopharmacol, 2018; 32:1319–1329.

Filiptsova OV , Gazzavi-Rogozina LV , Timoshyna IA , et al. The essential oil of rosemary and its effect on the human image and numerical short-term memory. Egypt J Basic Appl Sci, 2017; 4:107–111.

Reay JL , Scholey AB , Kennedy DO . Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults. Hum Psychopharmacol Clin Exp, 2010; 25:462–471.

Scholey A , Ossoukhova A , Owen L , et al. Effects of American ginseng (Panax quinquefolius) on neurocognitive function: An acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology (Berl), 2010; 212:345–356.

Chen EYH , Hui CLM . HT1001, a proprietary North American ginseng extract, improves working memory in schizophrenia: A double-blind, placebo-controlled study. Phytother Res, 2012; 26:1166–1172.

Ossoukhova A , Owen L , Savage K , et al. Improved working memory performance following administration of a single dose of American ginseng (Panax quinquefolius L.) to healthy middle-age adults. Hum Psychopharmacol, 2015; 30:108–122.

Kennedy DO , Scholey AB , Wesnes KA . Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults. Physiol Behav, 2002; 75:739–751.

Scholey AB , Kennedy DO . Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: Differential interactions with cognitive demand. Hum Psychopharmacol, 2002; 17:35–44.

Kennedy DO , Scholey AB , Wesnes KA . Differential, dose dependent changes in cognitive performance following acute administration of a Ginkgo biloba/Panax ginseng combination to healthy young volunteers. Nutr Neurosci, 2001; 4:399–412.

Wesnes KA , Ward T , McGinty A , et al. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl), 2000; 152:353–361.

Wesnes KA , Faleni RA , Hefting NR , et al. The cognitive, subjective, and physical effects of a ginkgo biloba/panax ginseng combination in healthy volunteers with neurasthenic complaints. Psychopharmacol Bull, 1997; 33:677–683.

Heo J-H , Lee S-T , Chu K , et al. An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimers disease. Eur J Neurol, 2008; 15:865–868.

Lee S-T , Chu K , Sim J-Y , et al. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis Assoc Disord, 2008; 22:222–226.

Heo J-H , Lee S-T , Chu K , et al. Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease. Nutr Neurosci, 2012; 15:278–282.